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ABSTRACT 
Chronic neuropathic pain is a common and widely recognized pain syndrome for patients and difficult to manage 
for physicians. Azadirachta indica (AI) possesses analgesic, anti-inflammatory, and antioxidant properties. To 
evaluate the neuroprotective effect of AI standardized extract in an animal model of peripheral neuropathy induced 
by partial sciatic nerve ligation (PSNL). PSNL was induced in male Wistar rats (180-200 g) with tight ligation of 
the nerve. Rats received treatment with either vehicle i.e. distilled water (PSNL control), Pyridoxine (100 mg/kg, 
p.o.) or AI (100, 200 and 400 mg/kg, p.o.) for 28 days. Various behavioral parameters, biochemical, molecular 
and histological parameters were evaluated. PSNL resulted in a significant decrease (p < 0.05) in allodynia, hy-
peralgesia, motor coordination and motor nerve conduction velocity (MNCV) whereas chronic treatment with AI 
(200 and 400 mg/kg) significantly attenuated (p < 0.05) these behavioral changes. Enhanced activity of oxidative-
nitrosative stress, inflammatory mediators (TNF-α, IL-1β, and NF-κB) as well as mRNA expression of Bax, 
Caspase-3, and iNOs were significantly attenuated (p < 0.05) by AI treatment. It also significantly increased (p < 
0.05) peripheral blood oxygen content and Bcl-2 mRNA expression. The flow cytometric analysis revealed that 
AI (200 and 400 mg/kg) treatment significantly attenuated neural apoptosis and reactive oxygen species levels. 
PSNL induced histological aberrations were also decreased by AI treatment. Azadirachta indica exerts its neuro-
protection against PSNL induced neuropathic pain via inhibition of oxidative-nitrosative stress, the release of pro-
inflammatory cytokines and apoptosis to improve MNCV (graphical abstract, Figure 1). 
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Inducible nitric oxide synthase (iNOs); Malondialdehyde (MDA); Motor Nerve Conduction Velocity (MNCV); 
Nuclear factor-kappaB (NF-κB); Polymerase Chain Reaction (PCR); Partial Sciatic Nerve Ligation (PSNL); Re-
active Oxygen Species (ROS); Superoxide Dismutase (SOD); Tumor Necrosis Factor-alpha (TNF-α) 
 
 
 
INTRODUCTION 
Neuropathic pain refers to pain as a result 
of damage (due to injury or disease) to the 
nervous system including nerves, spinal cord, 
and certain central nervous system (CNS) re-
gions (Zimmermann, 2001) with heterogene-
ous etiology and the complex pathophysiol-
ogy (Woolf and Mannion, 1999). Patients 
with diabetes, cancer, AIDS, leprosy, cervical 
disc protrusion and foraminotomy mainly suf-
fer from peripheral neuropathic pain (Garg 
and Dehran, 2010; Shaladi et al., 2009). Ac-
cording to World Health Organization, 
around 22 % of the world’s primary care pa-
tients suffer from chronic neuropathic pain 
and there is an urgent need to address this by 
all physicians and healthcare professionals 
(Lepine and Briley, 2004). 
An array of disease conditions where the 
generation of the neuropathic pain is reported 
is multiple sclerosis, Guillain-Barre A syn-
dromes (Pentland and Donald, 1994), inflam-
matory demyelinating polyneuropathies 
(Albers and Kelly, 1989), non-vasculitic ster-
oid-responsive mononeuritis (Logigian et al., 
1993). Damage to the nerve blood vessels and 
deficiency of pyridoxine (Vitamin B6) could 
cause peripheral neuropathy (Dellon et al., 
2001). To unravel the mechanisms that are re-
sponsible for generation and maintenance of 
neuropathic pain, the development of animal 
models of neuropathic pain is of great im-
portance (Koltzenburg, 1998). Various ani-
mal models have been reported to simulate 
clinicopathological conditions of peripheral 
neuropathic, most of which are based on pro-
cedures at or near sciatic nerves (Patil et al., 
2011). 
In animals, partial sciatic nerve ligation 
(PSNL), i.e. mechanical injury to the sciatic 
nerve, produces significant damage to 
myelinated fibers and disruption with loss of 
unmyelinated axons which results in the ap-
pearance of abnormal sensory sign such as al-
lodynia (pain response to low threshold stim-
ulus) and hyperalgesia (increased response to 
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noxious stimuli) which resembles the symp-
toms that were produced in humans (Bennett 
and Xie, 1988; Wieczorkiewicz-Plaza et al., 
2004). The pain produced after nerve ligation 
depends upon the degree of nerve trapped in 
the ligature (Wieczorkiewicz-Plaza et al., 
2004). After induction of peripheral nerve in-
jury, along with the appearance of allodynia 
and hyperalgesia, it also produces an 
alteration in peptide expression of DRG neu-
rons and dorsal horn (Takaishi et al., 1996). 
It has been reported that neutrophils, 
macrophages, and lymphocytes released from 
injured cells caused a central neuroimmune 
response which in turn stimulated activation 
of microglia and astrocytes (Inoue et al., 
1999; Kandhare et al., 2011). This activated 
glial cell plays a vital role in the subsequent 
production of cytokines and chemokines 
(Goswami et al., 2016; Kandhare et al., 
2015a). The elevated level of proinflamma-
tory cytokines causes release of cyclooxygen-
ase (COX)-2 and substance P which involves 
in nociceptive transmission (Aswar et al., 
2015; Brodin et al., 1986). The elevated levels 
of substance P caused induction of neuro-
pathic pain following peripheral nerve injury 
(Kajander and Xu, 1995). 
Synthetic chemical moieties like tricyclic 
anti-depressants (i.e., amitriptyline, nortrip-
tyline, and imipramine), anti-convulsants 
(i.e., phenytoin, carbamazepine, gabapentin, 
lamotrigine, and topiramate), pyridoxine 
(Vitamin B6), thiamine and cyanocobalamin 
are the present treatment regimens for neuro-
pathic pain (Botez and Herrmann, 2010; 
Dworkin et al., 2010). However, wide spec-
trums of adverse effects are associated with 
these classes of drugs which limit their utility 
in the management of neuropathic pain (Bril 
et al., 2011). Also, none of the medications 
has been found effective in Complex regional 
pain syndrome (CRPS) during the random-
ized clinical controlled trials (Kumar et al., 
2007; Thomson and Jacques, 2009). 
Drugs from herbal origin like Aconiti tu-
ber, Lindera angustifolia, Teucrium polium, 
Phyllanthus emblica, Vochysia divergens, 
Cannabis sativa, Nigella sativa, Ocimum 
sanctum and Ginkgo biloba have been re-
ported preclinically effective for the manage-
ment of neuropathic pain (Comelli et al., 
2008; Kanter, 2008; Kim and Chung, 1992; 
Muthuraman et al., 2008). Hence, new medi-
cines from herbal origin provide a ray of hope 
for the treatment of neuropathic pain.  
In Ayurveda, Azadirachta indica (Family: 
Meliaceae) has been reported to have antifun-
gal, antidiabetic, antibacterial, antiviral, con-
traceptive and sedative properties. It has been 
evaluated for a wide spectrum of diseases in-
cluding cancer, inflammation, ulcer, immune 
disorder, hyperlipidemia and liver disease 
(Botez and Herrmann, 2010; Chattopadhyay 
and Bandyopadhyay, 2005; Chattopadhyay, 
1996; Dasgupta et al., 2004; Elumalai et al., 
2012; Raji et al., 2004). It also possesses to 
have potential antinociceptive potential 
(Kanagasanthosh et al., 2016) however, its 
potential for neuropathic pain has not been 
evaluated yet. Hence, the aim of the present 
investigation was to study the effect of Aza-
dirachta indica in PSNL induced neuropathic 
pain in laboratory animals by assessing vari-
ous nerve functions, biochemical parameters, 
and molecular parameters. 
 
MATERIALS AND METHODS 
Animals 
Adult male Wistar rats (180-200 g) were 
obtained from the National Institute of Biosci-
ences, Pune (India). The animals were housed 
in groups of 7 in solid bottom polypropylene 
cages. They were maintained at 24 °C ± 1 °C, 
with a relative humidity of 45-55 % and 12:12 
h dark/light cycle. The acclimation period for 
animals were two weeks and they were main-
tained under pathogen-free conditions. The 
animals had free access to standard pellet 
chow (Chakan Oil Mills, Sangli) and water 
throughout the experimental protocol. All ex-
periments were carried out between 09:00 and 
17:00 h. The experimental protocols were ap-
proved by the Institutional Animal Ethics 
Committee (IAEC) of Poona College of Phar-
macy, Pune (CPCSEA/26/2012) and per-
formed in accordance with the guidelines of 
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Committee for Control and Supervision of 
Experimentation on Animals (CPCSEA), 
Government of India on animal experimenta-
tion. 
 
Drugs and chemicals 
Azadirachta indica leaf standardized ex-
tract (4.3  % Total bitters) was purchased 
from Natural Remedies Pvt. Ltd., Bangalore 
(Batch No. AI/08001). 1,1’,3,3’-Tetraethoxy-
propane, crystalline beef liver catalase, re-
duced glutathione (GSH), 5,5’-dithiobis (2-
nitrobenzoic acid) were purchased from S.D. 
Fine Chemicals, Mumbai, India. Total RNA 
Extraction kit and One-step RT-PCR kit was 
purchased from MP Biomedicals India Pri-
vate Limited, India. TNF-α, IL-1β, and NF-
κB ELISA kits were purchased from RayBi-
otech, Inc., Norcross GA.  
 
Extraction procedure for Azadirachta  
indica 
Coarse leaves of Azadirachta indica were 
extracted with water and filtered. The filtrate 
obtained was evaporated and dried under vac-
uum to obtain a brown powdered extract. The 
extract thus obtained was analyzed for 
physicochemical (as per the quality parame-
ters specified in USP 36, [which include anal-
ysis of heavy metals] pesticide residues and 
microbial count) and total bitters. The extract 
was found to contain 4.3 % bitters by gravim-
etry.  
 
Induction of partial sciatic nerve ligation 
(PSNL) induced neuropathy and drug  
treatment schedule 
All the required parameters were carried 
out in all selected rats before surgery. The 
neuropathic pain was induced in rats by PSNL 
according to the previously reported proce-
dure (Seltzer et al., 1990). The rats were 
anesthetized by intraperitoneal injection of 
Ketamine (80 mg/kg). Rectal temperature was 
maintained at 37 °C using a homeothermic 
blanket. The right sciatic nerve was exposed 
at high thigh level under aseptic condition. 
The dorsum of the nerve was carefully freed 
from surrounding connective tissues at a site 
near the trochanter just distal to the point at 
which the posterior biceps semitendinosus 
nerve branches off the common sciatic nerve. 
A 4-0 silk suture was inserted into the nerve 
with 3/8 curve, reverse-cutting mini needle 
and tightly ligated so that the dorsal 1/3 – 1/2 
of the nerve thickness was trapped in the lig-
ature. In sham-operated rats, the nerve was 
left intact (PSNL was not performed). After 
the surgical procedure, the wounds were 
closed with 2 muscle sutures and 3-4 skin su-
tures. In all rats, the left leg and sciatic nerve 
were remained untouched. Rats were treated 
with analgesic and antibiotic. Each animal 
was allowed recovered after surgery for 2 
days.  
The animals were divided randomly into 
groups with 10 rats per group as follows: 
Group I: Normal group: (N): The rats did 
not receive either surgery or injury or sciatic 
nerve. They received only vehicle (Distilled 
water (DW)). 
Group II: Sham group: (S): The rats were 
exposed to the sciatic nerve but did not re-
ceive injury. They received only vehicle 
(DW). 
Group III: PSNL control group: (PSNL): 
The rats were exposed to the sciatic nerve and 
receive injury by PSNL. They received only 
vehicle (DW). 
Group IV: Pregabalin treated group: 
(P(10)): The rats were exposed to the sciatic 
nerve and received injury. They were treated 
with Pregabalin at a dose of 10 mg/kg, p.o. 
Group V: AI (100) treated group: AI 
(100): The rats were exposed to the sciatic 
nerve and received injury. They were treated 
with AI at a low dose of 100 mg/kg, p.o. 
Group VI: AI (200) treated group: AI 
(200): The rats were exposed to the sciatic 
nerve and received injury. They were treated 
with AI at a medium dose of 200 mg/kg, p.o. 
Group VII: AI (400) treated group: AI 
(400): The rats were exposed to the sciatic 
nerve and received injury. They were treated 
with AI at a high dose of 400 mg/kg, p.o. 
The baseline readings were taken before 
initiation of the experimentation and drug 
treatment. The different doses of AI, i.e. 
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100 mg/kg, 200 mg/kg and 400 mg/kg as well 
as Pregabalin 10 mg/kg, were administered 
per oral from day 1 onwards. The treatment 
continued for 28 days. All the behavioral as-
says were performed by an observer blind to 
the drug administration on day 4, 7, 14, 21 and 
28 in the morning and doses were adminis-
trated immediately afterward.  
At the end of study, i.e. on 28th day, blood 
was collected from the animals by ROP 
(retro-orbital puncture) and centrifuged at 
7500 rpm for 15 minutes at 4 °C. Then serum 
was transferred by using micropipette in 
Eppendorf tubes and stored at 4 °C till 
analyzed. Then, the animal was sacrificed and 
sciatic nerve was collected and kept in liquid 
nitrogen (-70 °C) till analyzed. Few animals 
sciatic nerve was selected for histopathology 
evaluation. 
 
Behavioral tests 
Mechanical hyperalgesia (Randall-Selitto 
paw pressure test), Radiant heat test (Har-
greaves test), Thermal hyperalgesia, Mech-
ano-tactile allodynia (Von Frey hair test), 
Motor incoordination test (Rota-Rod test) and 
Motor nerve conduction velocity (MNCV) 
were performed in rats according to previ-
ously reported procedures (Kamble et al., 
2013; Kandhare et al., 2012a, b). 
 
Measurement of peripheral blood oxygen 
content 
The percentage of hemoglobin saturated 
with oxygen (pulse Ox) serves as an indicator 
of in vivo peripheral blood oxygen content. 
Rats were anesthetized with ether and a pe-
ripheral pulse Ox sensor (ChoiceMMed, 
V1.0CF3, MD300CF3, China) was attached 
to the paw. Pulse Ox readings were taken as 
the animal regained consciousness (Kandhare 
et al., 2015b).  
 
Biochemical estimations 
Sciatic nerve homogenate preparation 
50 mg sciatic nerve samples were rinsed 
with ice cold saline (0.9 % sodium chloride), 
minced and homogenized at 3000 rpm in 
chilled tris buffer (10 mM, pH 7.4) and di-
luted up to 5 ml. The homogenates were cen-
trifuged at 10,000 g at 0 °C for 20 min. It was 
divided into aliquot to determine superoxide 
dismutase (SOD), glutathione (GSH), 
malondialdehyde (MDA), total calcium con-
tent, nitric oxide content, membrane-bound 
inorganic phosphate enzyme, tumor necrosis 
factor-alpha (TNF-α), interleukin (IL)-1β and 
nuclear factor-kappaB (NF-κB) according to 
previously reported procedures (Adil et al., 
2016a, b; Kandhare et al., 2016, 2012d; 
Visnagri et al., 2015b). 
Estimation of TNF-α, IL-1β, and NF-κB 
The quantifications of TNF-α, IL-1β, and 
NF-κB were performed with the help and in-
structions provided by Thermo Scientific, 
USA Rat TNF-α, IL-1β and NF-κB immuno-
assay kit (Kandhare et al., 2013; Sarkate et al., 
2015; Visnagri et al., 2015a). The sample val-
ues are then read off the standard curve. Val-
ues were expressed as means ± S.E.M.  
Reverse transcriptase PCR  
The levels of mRNA were analyzed in sci-
atic nerve using a reverse transcription (RT)- 
Polymerase chain reaction (PCR) approach as 
described previously (Adil et al., 2016c, 
2014). Single-stranded cDNA was synthe-
sized from 5 µg of total cellular RNA using 
reverse transcriptase (MP Biomedicals India 
Private Limited, India) as described previ-
ously (Adil et al., 2014; Ketkar et al., 2015). 
The primer sequence for Bax, Bcl-2, Caspase-
3, iNOs and β-actin is presented in Supple-
mentary Table 1. Expression of all the genes 
was assessed by generating densitometry data 
for band intensities in different sets of exper-
iments and was generated by analyzing the 
gel images on the Image J program (Version 
1.33, Wayne Rasband, NIH, Bethesda, MD, 
USA) semi-quantitatively. The band intensi-
ties were compared with constitutively ex-
pressed β-actin. The intensity of mRNAs 
were standardized against that of the β-actin 
mRNA from each sample, and the results 
were expressed as PCR-product/β-actin 
mRNA ratio. 
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Preparation of single Schwann cell (SC) sus-
pensions 
Preparation of single Schwann cell (SC) 
suspensions and determination of apoptotic 
cell populations were determined as previ-
ously described (Kandhare et al., 2012a). At 
the end of treatment, the sciatic nerves of rats 
were collected and mixed with 0.4 % colla-
genase and 0.25 % Trypsin at 370 °C for 
30 min and dissociated, ground and the ob-
tained homogenate was passed through a 
70 μm nylon mesh. Single SC suspension was 
washed three times with phosphate-buffered 
saline (PBS). 
Flow cytometry analysis 
In order to determine SC apoptosis, the 
isolated SC were incubated with rabbit anti-
cow S-100 antibody and followed by staining 
with APC-goat anti-rabbit IgG (both from 
BD) with Fluorescein isothiocyanate (FITC)-
Annexin V and PI (Sigma). The percentages 
of expression of Fas and Annexin-Von gated 
S-100 positive SC were analyzed by an 
FACSCalibur cytometer using CellQuest 
software (Becton & Dickinson, San Diego, 
USA) (Kandhare et al., 2014). 
ROS production in SC by H2DCFDA probe 
using Flow Cytometry 
Reactive Oxygen Species (ROS) produc-
tion was quantified by using dichlorodihydro-
fluorescein diacetate (H2DCFDA) dye 
method based on the ROS-dependent oxida-
tion of DCFH-DA to DCF according to the 
method described elsewhere (Ghule et al., 
2015).  
 
Histopathological analysis 
On day 28th all animals were sacrificed 
and sciatic nerves were collected. Samples of 
sciatic nerve was kept in the fixative solution 
(10 % formalin) and it was processed for 
12 hr using isopropyl alcohol, xylene, and 
paraffin embedded for light microscopic 
study (Nikon E200). Paraffin-embedded tis-
sue section cut at 5 μm thickness were pre-
pared and staining was done by using hema-
toxylin and eosin. Nerve sections were ana-
lyzed qualitatively under a light microscope 
(400 X) for axonal degeneration, hemosiderin 
deposition, edema, neutrophil infiltration, 
nerve cell vacuolization, etc. 
 
Statistical analysis 
Data analysis was performed using 
GraphPad Prism 5.0 software (GraphPad, San 
Diego, USA). Statistical comparisons were 
made between drug-treated groups and dis-
ease control animals (PSNL control). Data of 
disease activity index were statistically ana-
lyzed using two-way repeated ANOVA, Bon-
ferroni’s multiple range test was applied for 
post hoc analysis, while data of biochemical 
parameters were analyzed using one-way 
ANOVA, Tukey’s multiple range test was ap-
plied for post hoc analysis. A value of p < 
0.05 was considered to be statistically signif-
icant. 
 
RESULT 
Effect of AI on PSNL induced alterations 
in mechanical allodynia in von Frey hair 
test and mechanical hyperalgesia in  
Randall-Selitto paw pressure test 
The mean paw-withdrawal threshold of 
normal rats as well as sham control rats before 
the induction of neuropathy did not signifi-
cantly differ as compared to PSNL control 
rats. Partial sciatic nerve ligation resulted in 
significant decreased (p < 0.05) mechano-tac-
tile allodynia and mechanical hyperalgesia, 
i.e. mean paw withdrawal threshold in PSNL 
control rats as compared to sham-operated 
rats. Chronic treatment with AI (100, 200 and 
400 mg/kg, p.o.) for 28 days significantly in-
creased (p < 0.05) paw withdrawal threshold 
when compared with PSNL control rats. Ad-
ministration of pregabalin (10 mg/kg, p.o.) 
also significantly increased (p < 0.05) me-
chanical nociceptive threshold as compared to 
PSNL control rats. When compared with 
pregabalin (10 mg/kg, p.o.) treated rats, AI 
(100, 200 and 400 mg/kg, p.o.) treated rats 
showed a more significant increase (p < 0.05) 
in mechanical allodynia and hyperalgesia. 
However, there was no significant change in 
mean paw withdrawal threshold in normal as 
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well as sham control group over the same time 
period (Figure 2A, B). 
 
Effect of AI on PSNL induced alterations 
in thermal hyperalgesia in paw withdrawal 
latency and tail withdrawal latency in  
Hargreaves test and tail immersion test 
Before the induction of neuropathy, there 
was no significant difference in mean paw as 
well as tail withdrawal latency i.e. reaction 
time in normal rats as compared to PSNL con-
trol rats as well as sham control rats. A signif-
icant decrease (p < 0.05) in paw withdrawal 
latency and tail withdrawal latency as pro-
duced in the PSNL control rats after induction 
of neuropathy on day 0 was seen as compared 
to sham-operated rats. Chronic administration 
of the AI (100, 200 and 400 mg/kg, p.o.) for 
28 days significantly increased (p < 0.05) the 
paw withdrawal latency and tail withdrawal 
latency as compared to PSNL control rats. 
Administration of pregabalin (10 mg/kg, p.o.) 
also significantly increased (p < 0.05) paw 
and tail withdrawal latency as compared to 
PSNL control rats. There was no significant 
change in paw withdrawal latency as well as 
a tail withdrawal latency in normal as well as 
sham control group over the same time period 
(Figure 2C, D). 
 
Effect of AI on PSNL induced alterations 
in motor incoordination test 
There was no significant difference in fall 
off time in PSNL control rats as compared to 
normal rats as well as sham control rats before 
the induction of neuropathy. Induction of neu-
ropathy by partial sciatic nerve ligation re-
sulted in significant decrease in fall off time, 
i.e. motor incoordination in PSNL control rats 
as compared to sham-operated rats on day 0. 
Chronic administration of AI (100, 200 and 
400 mg/kg, p.o.) for 28 days significantly at-
tenuated (p < 0.05) these partial sciatic nerve 
ligation-induced a decrease in motor perfor-
mance i.e. mean fall off time as compared to 
PSNL control rats. When compared with 
PSNL control rats, pregabalin (10 mg/kg, 
p.o.) treatment showed a significant increase 
(p < 0.05) in motor performance. Sham con-
trol rats did not show any significant altera-
tions in fall off time as compared to normal 
rats over the same time period (Figure 2E). 
 
Effect of AI on PSNL induced alterations 
in motor nerve conduction velocity 
Motor nerve conduction velocity did not 
differ significantly in PSNL control rats as 
compared to sham control or normal rats be-
fore induction of neuropathy on day 0. Partial 
sciatic nerve ligation resulted in significant 
decrease (p < 0.05) in motor nerve conduction 
velocity in PSNL control rats as compared to 
sham-operated rats. Chronic administration of 
AI (100, 200 and 400 mg/kg, p.o.) for 28 days 
resulted in a significant increase (p < 0.05) in 
motor nerve conduction velocity as compared 
to PSNL control rats. Treatment with pregab-
alin (10 mg/kg, p.o.) also showed a significant 
increase (p < 0.05) in motor nerve conduction 
velocity as compared to PSNL control rats. 
Motor nerve conduction velocity did not dif-
fer significantly in normal rats as compared to 
sham control rats over the same time period 
(Figure 2F). 
 
Effect of AI on PSNL induced alterations 
in neural oxido-nitrosative level 
Induction of neuropathy by PSNL re-
sulted in a significant decrease (p < 0.05) in 
SOD and GSH level in sciatic nerve of PSNL 
control rats as compared to sham control rats 
and normal rats. After chronic administration 
of AI (200 and 400 mg/kg, p.o.) for 28 days, 
the SOD and GSH level was significantly in-
creased when compared with PSNL control 
rats (Table 1).  
Partial sciatic nerve ligation resulted in 
significant increase (p < 0.05) in MDA and 
NO level in sciatic nerve of PSNL control rats 
as compared to sham operated and normal 
rats. After 28 days of AI treatment (200 and 
400 mg/kg, p.o.), MDA and NO level were 
decreased significantly as compared to PSNL 
control rats. Administration of pregabalin (10 
mg/kg, p.o.) also significantly inhibited PSNL 
induced alteration in neural oxido-nitrosative 
level when compared with PSNL control rats. 
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Figure 2: Effect of Azadirachta indica on PSNL-induced alterations in (A) Mechanical allodynia in von 
Frey hair test, (B) Mechanical hyperalgesia in paw pressure test, (C) Thermal hyperalgesia in plantar 
test, (D) Thermal hyperalgesia in Hargreaves test, (E) fall off time in rotarod test and (F) Motor nerve 
conduction velocity. Data are expressed as mean ± S.E.M. from six rats and analyze by two-way ANOVA 
followed by Bonferroni’s test.  
*p < 0.05 as compared to PSNL control group, #p < 0.05 as compared to normal and sham control animals and $p < 0.05 as 
compared to one another group. N: Normal rats; S: Sham control rats; PSNL: Partial Sciatic Nerve Ligation control rats, P (10): 
Pregabalin (10 mg/kg, p.o.) treated rats, AI (100): Azadirachta indica (100 mg/kg, p.o.) treated rats, AI (200): Azadirachta indica 
(200 mg/kg, p.o.) treated rats and AI (400): Azadirachta indica (400 mg/kg, p.o.) treated rats. 
 
 
However, there was no significant differ-
ence in the SOD, GSH, MDA and NO level 
of sham control rats as compared to normal 
rats (Table 1). 
 
Effect of AI on PSNL induced alterations 
in neural calcium and Na-K-ATPase level  
Partial sciatic nerve ligation resulted in 
a significant increase (p < 0.05) in neural 
calcium level whereas it significantly de-
creased in Na-K-ATPase level in PSNL 
control rats when compared with sham-
operated rats and normal rats. The 28-day 
treatment of AI (200 and 400 mg/kg, p.o.) 
significantly decreased (p < 0.05) in neural 
calcium level as compared to PSNL control 
rats. Na-K-ATPase level was increased sig-
nificantly (p < 0.05) in AI (200 and 400 
mg/kg, p.o.) treated rats when compared 
with PSNL control rats. Pregabalin (10 
mg/kg, p.o.) treatment significantly in-
creased (p < 0.05) neural Na-K-ATPase 
level and significantly decreased (p < 0.05) 
neural calcium level as compared to PSNL 
control rats (Table 1Fehler! Verweisquelle 
konnte nicht gefunden werden.). 
 
Effect of AI on PSNL induced alterations 
in peripheral blood oxygen content 
After 28 day duration of induction of 
neuropathy by partial sciatic nerve ligation, 
peripheral blood oxygen content of PSNL 
control rats significantly decreased (p < 
0.05) as compared to normal rats as well as 
sham-operated rats. After 28 days of 
chronic treatment with AI (200 and 400 
mg/kg, p.o.), peripheral blood oxygen con-
tent was significantly increased (p < 0.05) 
as compared to PSNL control rats. PSNL in-
duced decrease in peripheral blood oxygen 
was significantly increased (p < 0.05) by 
pregabalin (10 mg/kg, p.o.) treatment. Pe-
ripheral blood oxygen content did not differ 
significantly in normal rats as well as sham 
control rats over the same time period (Ta-
ble 1).
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Table 1: Effect of Azadirachta indica on PSNL-induced alterations in neural SOD, GSH, MDA, NO, Calcium, Na-K-ATPase and Pulse Ox levels 
Treatment SOD  
(U/mg of protein) 
GSH  
(µg/mg  
protein) 
MDA  
(nM/mg  
of protein) 
NO  
(µg/mL) 
Ca  
(ppm/mg of  
protein) 
Na-K-ATPase 
(µmoles/mg of 
protein) 
Pulse Ox  
(% O2 saturation) 
Normal 28.22 ± 2.27 1.84 ± 0.45 2.15 ± 0.54 104.23 ± 12.30 5.11 ± 2.12 11.52 ± 2.02 96.55 ± 2.10 
Sham 27.11 ± 1.88 1.51 ± 0.78 2.11 ± 0.78 110.32 ± 15.62 4.85 ± 1.30 10.25 ± 1.88 95.78 ± 3.12 
PSNL 2.25 ± 0.85# 0.11 ± 0.08# 8.54 ± 1.02# 345.63 ± 17.32# 20.23 ± 2.62# 2.51 ± 0.41# 85.85 ± 1.95# 
P (10) 25.62 ± 0.89*,$ 1.05 ± 0.14*,$ 3.84 ± 0.15*,$ 245.62 ± 11.02*,$ 6.55 ± 1.62*,$ 7.62 ± 0.23*,$ 92.23 ± 2.44*,$ 
AI (100) 5.62 ± 0.44 0.21 ± 0.08 6.55 ± 1.87 340.23 ± 21.03 18.62 ± 2.02 3.26 ± 0.54 86.52 ± 2.11 
AI (200) 14.23 ± 1.84*,$ 0.78 ± 0.15*,$ 4.23 ± 1.55*,$ 300.26 ± 11.25* 11.52 ± 2.04*,$ 5.62 ± 1.00* 89.95 ± 2.84*,$ 
AI (400) 20.78 ± 2.78*,$ 1.05 ± 0.15*,$ 3.65 ± 0.54*,$ 275.62 ± 14.62*,$ 8.62 ± 1.05*,$ 8.65 ± 2.01*,$ 92.87 ± 3.45*,$ 
 
Data was analyzed by One-Way ANOVA followed by Tukey’s multiple range test.  
*p < 0.05 compared with the PSNL control group, #p < 0.05 compared with normal and sham control group and $p < 0.05 compared with one another. PSNL: Partial Sciatic Nerve Ligation Control,  
P (10): Pregabalin (10 mg/kg, p.o.), AI (100): Azadirachta indica (100 mg/kg, p.o.), AI (200): Azadirachta indica (200 mg/kg, p.o.) and AI (400): Azadirachta indica (400 mg/kg, p.o.) (n=4-5) 
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Effect of AI on PSNL induced alterations 
in neural TNF-α, IL-1β, and NF-κB  
levels 
TNF-α, IL-1β and NF-κB levels in sci-
atic nerve of PSNL control rats were signif-
icantly increased (p < 0.05) after induction 
of neuropathy as compared to normal as 
well as sham control rats. Chronic treatment 
with AI (200 and 400 mg/kg, p.o.) resulted 
in significant decrease (p < 0.05) in ele-
vated neural TNF-α, IL-1β and NF-κB level 
as compared to PSNL control rats. Pregab-
alin (10 mg/kg, p.o.) treatment significantly 
decreased elevated neural TNF-α, IL-1β 
and NF-κB levels as compared to PSNL 
control rats. There was no significant differ-
ence in neural TNF-α, IL-1β and NF-κB 
levels of sham control rats as compared to 
normal rats over the same time period (Ta-
ble 2). 
 
Effect of AI on PSNL induced alterations 
in neural Bax, Bcl-2, Caspase-3 and iNOs 
mRNA level  
Partial sciatic nerve ligation resulted in 
significant up-regulation (p < 0.05) in neu-
ral Bax, Caspase-3 and iNOs mRNA ex-
pression level as significant down-regula-
tion in neural Bcl-2 mRNA expression in 
PSNL control rats as compared to sham-
operated as well as normal rats. After 28 
days of AI (200 and 400 mg/kg, p.o.) treat-
ment, neural Bax, Caspase-3, and iNOs 
mRNA expression level were significantly 
down-regulated (p < 0.05) as compared to 
PSNL control rats. The down-regulated 
neural Bcl-2 mRNA expression was signif-
icantly up-regulated by AI (200 and 
400 mg/kg, p.o.) treatment as compared to 
PSNL control rats. The altered neural Bax, 
Bcl-2, Caspase-3 and iNOs mRNA levels 
were significantly attenuated by pregabalin 
(10 mg/kg, p.o.) treatment as compared to 
PSNL control rats (Figure 3). 
 
Effect of AI on PSNL induced alterations 
in neural apoptosis and ROS levels 
Apoptosis and ROS in sciatic nerve of 
PSNL control rats were significantly in-
creased as compared to sham-operated as 
well as normal rats. PSNL induced increase 
in apoptosis and ROS was significantly de-
creased by AI (200 and 400 mg/kg) treat-
ment as compared to PSNL control rats. 
Rats treated with pregabalin (10 mg/kg, 
p.o.) also significantly inhibited this ele-
vated level of apoptosis and ROS as com-
pared to PSNL control rats (Figure 4 and 
Figure 5). 
 
 
 
 
Table 2: Effect of Azadirachta indica on PSNL-induced alterations in neural TNF-α, IL-1β, and NF-κB 
levels 
Treatment TNF-α (pg/mL) IL-1β (pg/mL) NF-κB (pg/mL) 
Normal 57.45 ± 1.52 18.54 ± 1.07 30.52 ± 4.62 
Sham 55.42 ± 2.54 17.65 ± 4.21 34.62 ± 1.55 
PSNL 187.65 ± 7.54# 104.55 ± 3.82# 276.65 ± 5.62# 
P (10) 102.42 ± 2.11*,$ 54.85 ± 3.55*,$ 124.07 ± 3.98*,$ 
AI (100) 181.21 ± 3.47 105.01 ± 2.78 244.12 ± 3.22 
AI (200) 115.65 ± 3.22*,$ 84.54 ± 2.17*,$ 157.41 ± 2.78*,$ 
AI (400) 84.65 ± 1.74*,$ 47.65 ± 1.48*,$ 85.11 ± 2.87*,$ 
Data was analyzed by One-Way ANOVA followed by Tukey’s multiple range test.  
*p < 0.05 compared with the PSNL control group, #p < 0.05 compared with normal and sham control group and $p < 0.05 compared 
with one another. PSNL: Partial Sciatic Nerve Ligation Control, P (10): Pregabalin (10 mg/kg, p.o.), AI (100): Azadirachta indica 
(100 mg/kg, p.o.), AI (200): Azadirachta indica (200 mg/kg, p.o.) and AI (400): Azadirachta indica (400 mg/kg, p.o.) (n=4-5) 
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Figure 3: Effect of Azadirachta indica on PSNL-induced alterations in mRNA expression of Bax, Bcl-2, 
Caspase-3 and iNOs in sciatic nerve as determined by relative quantification by reverse transcriptase 
polymerase chain reaction analysis (A), Quantitative representation of mRNA expression of Bax, Bcl-2, 
Caspase-3 and iNOs (B-E). Data are expressed as mean ± S.E.M. from six rats and were analyzed by 
One-way ANOVA followed by Tukey’s test. 
*p < 0.05 as compared to PSNL control group, #p < 0.05 as compared to normal and sham control animals and $p < 0.05 as 
compared to one another group. N: Normal rats; S: Sham control rats; PSNL: Partial Sciatic Nerve Ligation control rats, P (10): 
Pregabalin (10 mg/kg, p.o.) treated rats, AI (100): Azadirachta indica (100 mg/kg, p.o.) treated rats, AI (200): Azadirachta indica 
(200 mg/kg, p.o.) treated rats and AI (400): Azadirachta indica (400 mg/kg, p.o.) treated rats. 
 
 
Figure 4: Effect of Azadirachta indica on PSNL-induced alterations in neural apoptosis. Representative 
image of FACS analysis using Annexin V/FITCPI stain (A-G) and percentage necrotic cells population 
(G). Four distinct cell distribution patterns are visible: normal viable cells (lower left quadrant), apoptotic 
cells (lower right quadrant), late apoptotic or necrotic cells (upper right quadrant) and necrotic cells 
(upper left quadrant). Data are expressed as mean ± S.E.M. from six rats and were analyzed by One-
way ANOVA followed by Tukey’s test.  
*p < 0.05 as compared to PSNL control group, #p < 0.05 as compared to normal and sham control animals and $p < 0.05 as 
compared to one another group. N: Normal rats; S: Sham control rats; PSNL: Partial Sciatic Nerve Ligation control rats, P (10): 
Pregabalin (10 mg/kg, p.o.) treated rats, AI (100): Azadirachta indica (100 mg/kg, p.o.) treated rats, AI (200): Azadirachta indica 
(200 mg/kg, p.o.) treated rats and AI (400): Azadirachta indica (400 mg/kg, p.o.) treated rats. 
EXCLI Journal 2017;16:546-565 – ISSN 1611-2156 
Received: January 21, 2017, accepted: March 22, 2017, published: April 18, 2017 
 
 
557 
 
Figure 5: Effect of Azadirachta indica on PSNL-induced alterations in neural ROS generation. Repre-
sentative images of FACS analysis using H2DCFD stain (A-E) and percentage ROS (G). Data are ex-
pressed as mean ± S.E.M. from six rats and were analyzed by One-way ANOVA followed by Tukey’s 
test. 
*p < 0.05 as compared to PSNL control group, #p < 0.05 as compared to normal and sham control animals and $p < 0.05 as 
compared to one another group. N: Normal rats; S: Sham control rats; PSNL: Partial Sciatic Nerve Ligation control rats, P (10): 
Pregabalin (10 mg/kg, p.o.) treated rats, AI (100): Azadirachta indica (100 mg/kg, p.o.) treated rats, AI (200): Azadirachta indica 
(200 mg/kg, p.o.) treated rats and AI (400): Azadirachta indica (400 mg/kg, p.o.) treated rats. 
 
 
 
Effect of AI on the histopathological 
alteration of sciatic nerve caused by 
PSNL 
Figure 6A and B depicted the normal ar-
chitecture of sciatic nerve from normal and 
sham control rats. It’s devoid of any infil-
tration of neutrophils, edema, nerve cell 
vacuolization and necrosis. Partial nerve li-
gation caused histopathological alterations 
in sciatic nerve of PSNL control rats. Histo-
logical evaluation of sciatic nerve from 
PSNL control rats showed axonal degener-
ation evident by the decrease in a number of 
myelinated fibers along with swelling of 
nonmyelinated and myelinated nerve fibers. 
It also showed infiltration of neutrophils 
and lymphocytes (red arrow) in the nerve 
tissues (Figure 6C). Also, fiber dearrange-
ment was noted and showed an elevated 
level of intracellular edema formation 
(black arrow) along with tissue necrosis 
(yellow arrow). However, administration of 
AI (200 and 400 mg/kg) attenuated PSNL 
induced axonal degeneration and histo-
pathological alterations. It shows mild lym-
phocytic infiltration (red arrow) and edema 
(black arrow) (Figure 6E and F). Figure 6D 
depicted the histopathological architecture 
of sciatic nerve tissues from pregabalin (10 
mg/kg, p.o.) treated rats reflected attenua-
tion of PSNL-induced neutrophilic as well 
as lymphocytic infiltration, edema, and ne-
crosis in the nerve fibers (Table 3Fehler! 
Verweisquelle konnte nicht gefunden 
werden.). 
 
DISCUSSION 
Partial sciatic nerve ligation model of 
peripheral neuropathic pain mimics most of 
the important characteristic features of neu-
rogenic pain in patients after peripheral 
nerve injury, therefore, it is widely accepted 
and a widely used model of peripheral neu-
ropathic pain (Jain et al., 2009; Muthu-
raman et al., 2008).  
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Figure 6: Effect of Azadirachta indica on PSNL-induced alterations in the histopathology of the sciatic 
nerve. Photomicrographs of sections of sciatic nerve from rats stained with H & E. Sciatic nerve micro-
scopic image of (A) Normal rats; (B) Sham control rats; (C) Partial Sciatic Nerve Ligation control rats, 
(D) Pregabalin (10 mg/kg, p.o.) treated rats, (E) Azadirachta indica (200 mg/kg, p.o.) treated rats and 
(F) Azadirachta indica (400 mg/kg, p.o.) treated rats. 
 
 
Table 3: Effect of Azadirachta indica on PSNL-induced alterations in histopathology of sciatic nerve in 
rats 
Treatment Infiltration of  
neutrophils 
Congestion Edema Necrotic changes 
in nerve 
Nerve cell  
vacuolization 
Normal - - + - + 
Sham - - + + - 
PSNL ++++ +++ +++ ++++ +++ 
P (10) + - + + + 
AI (200) ++ ++ ++ ++ ++ 
AI (400) + + + + + 
 
Note:  
0: no abnormality detected  
+: damage/ active changes up to less than 25 % 
++: damage/ active changes up to less than 50 % 
+++: damage/ active changes up to less 75 % 
++++: damage/ active changes up to more than 75 % 
 
 
 
It has been documented that sensitization 
of primary afferent nerves is responsible for 
generation and maintenance of hyperalgesia 
(Kim and Chung, 1992). During chronic neu-
ropathic pain, there is an elevated level of po-
tassium ion and substance P in spinal C-fiber 
that caused decrease in stimulation threshold 
of physical and thermal receptors (Levy and 
Zochodne, 2000). Unilateral partial sciatic 
nerve ligation resulted in a decrease of me-
chanical allodynia and thermal hyperalgesia 
ipsilaterally which produced within post 
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hours of surgery and are maintained for 
months. Our results are in coincidence with 
the previous finding (Kim and Chung, 1992) 
where unilateral partial sciatic nerve ligation 
resulted in inflammation which may be due to 
the release of inflammatory mediators such as 
bradykinin, nitric oxide, and a gene-related 
peptide calcitonin. However, chronic treat-
ment with AI significantly attenuated de-
creased level of mechanical allodynia and 
thermal hyperalgesia in sciatic nerve ligated 
animals indicating its therapeutic potential 
against neuropathic pain. The results of the 
present investigation coincided with the ear-
lier works which proved credence to the anal-
gesic and anti-inflammatory activity of Aza-
dirachta indica (Srinivasa et al., 2014). The 
findings of the present investigation suggest 
that AI plays an important role in pain regula-
tion at the peripheral level.  
Central sensitization of neurons is a result 
of damages of the motor as well as sensory 
fibers due to partial sciatic nerve ligation thus 
causes a decrease in thermal withdrawal la-
tency. Tail flick method is a useful technique 
for the evaluation of peripherally as well as 
centrally acting analgesic drugs (Wang et al., 
2005). In the present study, we were able to 
confirm this thermal hyperalgesia using an in-
dependent measure of the force of hind limb 
withdrawal elicited by graded thermal stimuli. 
Treatment with AI significantly increased tail 
withdrawal latency in partial sciatic nerve li-
gated rats. 
There is increasing evidence that PSNL 
was associated with elevated level of neural 
calcium (Jain et al., 2009). The rise in calcium 
level stimulates generation of secondary mes-
sengers, i.e. activation of calcium binding 
protein as well as calcium dependent kinase 
and phosphatase action. It caused a disturb-
ance in the normal homeostasis function of 
the nervous system as well as increased auto-
destruction with long-term potentiation, long-
term depression and neuronal hyperexcitation 
(Young, 1992). It has been documented that 
activated calpains and calmodulin was re-
sponsible for causing alteration of stability of 
axonal cytoskeleton protein thereby axonal 
degeneration (Raygude et al., 2012; Visnagri 
et al., 2014). Chronic treatment with AI exerts 
its neuroprotective effect via attenuating the 
elevated level of neuronal calcium. 
PSNL is associated with the generation of 
a vicious cycle that comprises of release of 
toxic substances from neutrophils and macro-
phages leading to generation and accumula-
tion of reactive oxygen species (ROS) as well 
as inflammatory cytokines (Bridges et al., 
2001). Furthermore, nitric oxide (NO) is an 
unconventional intracellular messenger in the 
nervous system and its elevated level associ-
ated with sensitized spinal as well as central 
neurons (Lin et al., 1999). NO reacts with 
ROS and acts as an oxidant (Adil et al., 2015; 
Badole et al., 2015; Kamble et al., 2013). Re-
action with deficient superoxide dismutase 
leads to the production of notorious peroxyni-
trite, which affects any cell molecule 
(Honmore et al., 2015, 2016). The increase in 
NO level is the result of tissue toxicity caused 
by damage of nerve. In the present 
investigation, the level of nitric oxide (NO) 
was increased due to injury to sciatic nerve 
which concerned in neuropathic pain (Levy 
and Zochodne, 2004). Treatment of AI inhib-
ited the elevated level of oxido-nitrosative 
stress in sciatic nerve and elucidates its neu-
roprotective effect. The finding of the present 
investigation was in line with previously pub-
lished experimental evidence (Dasgupta et al., 
2004). 
Previously it has been shown that a con-
spicuous inflammatory reaction, an immune 
cell infiltration and increased endoneurial lev-
els of pro-inflammatory cytokines (including 
TNF-α, interleukin-1β, and interleukin-6) de-
tected at the site of nerve injury in animal 
models of painful peripheral neuropathy 
(DeLeo et al., 1997). TNF-α and IL-1β as 
important mediators of neuropathic pain play 
an important role in initiation and mainte-
nance of neuropathic pain (Ignatowski et al., 
1999). Nuclear factor kappa B (NF-κB) is a 
transcription factor that can be activated by 
these cytokines (Aswar et al., 2015; Kandhare 
et al., 2012c). It plays a crucial role during in-
flammation, injury and neuronal plasticity for 
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glial and neuronal cell (Ma and Bisby, 1998). 
In the present investigation injury to sciatic 
nerve causes an increase in levels of pro-in-
flammatory cytokines including TNF-α and 
IL-1β. Our finding provides credence to the 
previous finding (Gustafson-Vickers et al., 
2008). Treatment with AI inhibited the re-
lease of inflammatory cytokine and thus NF-
κB which may be due to the virtue of its anti-
inflammatory property and reversed the neu-
ropathic pain.  
It is well known that membrane-bound en-
zyme Na+K+ATPase plays an important role 
in the generation of the transmembraneous 
Na+K+ gradient by catalyzing the hydrolysis 
of ATP (Patil et al., 2015; Visnagri et al., 
2013). The physiochemical state of the lipid 
environment regulates the activity of these 
membrane-bound enzymes. The increase in 
membrane fluidity caused enhanced activity 
of Na+K+ATPase (Visnagri et al., 2012). The 
decrease in Na+K+ATPase in sciatic nerve ho-
mogenate indicated failure of the Na-K-
pump, which required to expel intracellular 
Na ions (Mohod et al., 2016; Mukherjee et al., 
2015). The increase in pain pursued by ani-
mals is due to failure of Na+K+ATPase lead-
ing to neuropathic symptoms in the animals. 
The results of the present study indicated AI 
treatment significantly restores decrease level 
of Na+K+ATPase which was localized and 
distributed on the cytoplasmic side of the ax-
onal membrane, confirming the role of this 
enzyme in the transmission of electrical sig-
nals. 
PSNL affects impulse generation along 
with alterations in the pattern of action poten-
tial activity (Kandhare et al., 2012a). Further-
more, pathological characteristics of ligated 
sciatic nerve include various abnormalities in-
cluding loss of myelinated nerve fiber, axonal 
degeneration. Axonal degeneration of periph-
eral nerves leads to dysfunction of Schwann 
cells that resulted in delayed MNCV in PSNL 
control animals. The histopathological results 
also support these findings where sciatic 
nerve from PSNL control rats showed loss of 
myelinated nerve fiber. Furthermore, demye-
linated nerve injury leads to a significant de-
crease in the percentage of hemoglobin oxy-
gen saturation (Radhakrishnan et al., 2006). 
The pulse Ox investigation in the present 
study showed that treatment with AI caused a 
significant increase in the percentage of he-
moglobin oxygen saturation which in turn en-
hances nerve conduction velocity via decreas-
ing pathological damage. 
Cell apoptosis in integral part of various 
neurodegenerative conditions and inducible 
nitric oxide synthase (iNOS) has been re-
ported to play a vital role in either apoptosis 
or necrosis (Devkar et al., 2016; Kandhare et 
al., 2015d; Pannu and Singh, 2006). Further-
more, the balance between Bcl-2-associated 
X protein (Bax) and B-cell lymphoma 2 (Bcl-
2) has an important factor in cell survival 
(Kandhare et al., 2015c; Oltvai et al., 1993). 
Literature punctuated with the evidence 
showed that sciatic nerve of PSNL rats asso-
ciated with decreased Bcl-2 expression. The 
researcher reported that prior to apoptotic cell 
death, caspase signaling is responsible for 
generation and maintenance of the pain in the 
small fiber peripheral neuropathy (Joseph and 
Levine, 2004). Caspase-3 plays a vital role 
during the apoptosis via cleavage of caspase-
related proteins (Adil et al., 2015; Kandhare 
et al., 2015d). In the present study, we also 
found up-regulated mRNA expressions of 
Bax and caspase-3 whereas down-regulated 
Bcl-2 mRNA expression in PSNL control 
rats. Treatment with AI significantly pre-
vented PSNL induced alterations in these 
apoptotic mRNA expressions in sciatic nerve. 
Flow cytometric analysis also supports these 
findings where the population of early apop-
totic cells was decreased after AI treatment. 
Results of the present investigation 
corroborate with the findings of previous in-
vestigator depicting anti-apoptotic potential 
of AI (Elumalai et al., 2012). 
Recently some herbal drugs have been re-
ported clinically for attenuation of neuro-
pathic pain successfully (Babbar et al., 2009; 
Ellis et al., 2009). Patient receiving single in-
halation of tetrahydrocannabinol (25 mg, 
three times daily for five days) has been 
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shown to reduce the intensity of pain (Ware et 
al., 2010). Hence, our finding suggests that 
Azadirachta indica elucidates its neuropro-
tective effect in partial sciatic nerve ligation-
induced neuropathic pain by virtue of its anti-
oxidant, anti-inflammatory, anti-apoptotic 
potential. 
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